• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human RPL7L1 Polyclonal Antibody, FITC conjugated

The antibody against RPL7L1 was raised in rabbit using the Recombinant Human 60S ribosomal protein L7-like 1 protein (1-246AA) as the immunogen. This antibody exists as a fitc conjugated isotype IgG, purified by protein G with a purity greater than 95%.

ADC-19838A

The antibody against RPL7L1 was raised in rabbit using the Recombinant Human 60S ribosomal protein L7-like 1 protein (1-246AA) as the immunogen. This antibody exists as a fitc conjugated isotype IgG, purified by protein G with a purity greater than 95%.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-19838A ClonalityPolyclonal
Host SpeciesRabbitTarget NameRPL7L1
Target SynonymsRPL7L1 antibody; 60S ribosomal protein L7-like 1 antibody; Large ribosomal subunit protein uL30-like 1 antibodyFormLiquid
Species ReactivityHumanIsotypeIgG
Storage Buffer0.01M PBS, 0.03% Proclin 300; Constituents: 50% Glycerol, PH 7.4Purification Method>95%, Protein G purified
ConjugateFITC conjugatedStorageUpon receipt

Immunogen Information


Immunogen DescriptionRecombinant Human 60S ribosomal protein L7-like 1 protein (1-246AA)Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ6DKI1
Background Information
  • Uniprot Id

    Q6DKI1

  • Target Species

    Human

  • Target Name

    RPL7L1

  • Target Full Name

    Ribosomal protein uL30-like

  • Target Synonyms

    RPL7L1; 60S ribosomal protein L7-like 1; Large ribosomal subunit protein uL30-like 1

Inquire Rabbit anti-Human RPL7L1 Polyclonal Antibody, FITC conjugated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification